Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
National Cancer Institute (NCI)
Genmab
Seagen Inc.
Mayo Clinic
Hoffmann-La Roche
Erasca, Inc.
University of Oklahoma
USWM, LLC (dba US WorldMeds)
City of Hope Medical Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Pfizer
ImmunityBio, Inc.
AgonOx, Inc.
Novartis
Amgen
Inhibrx Biosciences, Inc
Incyte Corporation
National Cancer Institute (NCI)
University Health Network, Toronto
NeoTX Therapeutics Ltd.
HiFiBiO Therapeutics
HiFiBiO Therapeutics
Seattle Children's Hospital
AstraZeneca
GlaxoSmithKline
M.D. Anderson Cancer Center
Tesaro, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Valo Therapeutics Oy
Cancer Research UK
Milton S. Hershey Medical Center
Toray Industries, Inc
Eli Lilly and Company
N.N. Petrov National Medical Research Center of Oncology
University of Toronto
Salubris Biotherapeutics Inc
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
ENB Therapeutics, Inc
RemeGen Co., Ltd.
NantBioScience, Inc.
NGM Biopharmaceuticals, Inc
Adaptimmune